GLP-1 drugs like Ozempic may have health benefits, but they …
2 days ago · The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists, …
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
About 1 in 8, or 12%, reported ever taking the "increasingly popular class of prescription drugs [GLP-1] used for weight loss and to treat diabetes or prevent heart attacks or strokes for adults ...
GLP-1 pills are coming, and they could revolutionize weight-loss …
Sep 17, 2024 · At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final …
GLP-1s for weight loss have heart benefits, too - Sanford Health News
5 days ago · It is the medication’s role in slowing digestion and increasing how full you feel that can lead to weight loss. Why GLP-1s can be effective. Weight loss drugs have been around …
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and …
4 days ago · A more advanced age at baseline is significantly associated (P < 0.02) with reduced weight, BMI, and waist circumference loss from GLP-1 RAs. For every increase in age by 1 …
Popular GLP-1 medications may have health benefits that extend …
6 days ago · Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, …
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss
6 days ago · TUESDAY, Jan. 21, 2025 (HealthDay News) -- Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such …
GLP-1 nonresponders: Up to 1 in 5 people don't lose weight | AP News
Nov 23, 2024 · In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. …
Many people using GLP-1s for weight loss stop treatment too soon ... - CNN
May 21, 2024 · An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications – about 58% – were on their treatment plan for less than 12 weeks, …
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound. Some of the …